10-year Data on Oral Selexipag: Long-Term Survival, Safety, and Dosing Insights in Pulmonary Arterial Hypertension (PAH) from the GRIPHON Study and Its Open-Label Extension (OLE)

Authors
Category Systematic review
Conference57th ASH Annual Meeting
Year 2025
This article has no abstract
Epistemonikos ID: b43102ab69fdfab2e291439b0f6040ed01c1ef66
First added on: Jan 23, 2026